Alligator Bioscience AB (publ) (STO:ATORX)

Alligator Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	132	15	189	453	342	567
Market Cap Growth	98.57%	-92.20%	-58.27%	32.59%	-39.69%	-0.11%
Enterprise Value	131	27	151	348	213	499
Last Close Price	0.21	0.34	249.00	689.00	1550.00	2570.00
PS Ratio	253.05	17.59	3.28	7.65	9.50	42.54
PB Ratio	3.19	2.15	-1.45	38.24	3.84	2.01
P/TBV Ratio	108.66	-	-	-	4.81	2.15
EV/Sales Ratio	251.91	32.05	2.62	5.87	5.93	37.45
Debt / Equity Ratio	0.78	6.29	-1.38	1.36	0.28	0.03
Net Debt / Equity Ratio	-0.01	-2.78	-0.89	-4.22	-0.82	-0.95
Net Debt / EBITDA Ratio	0.01	0.17	-0.51	0.20	0.39	1.96
Net Debt / FCF Ratio	0.00	0.12	-0.52	0.26	0.42	2.11
Asset Turnover	0.01	0.01	0.52	0.41	0.14	0.06
Quick Ratio	1.21	0.87	0.35	0.76	1.79	6.21
Current Ratio	1.76	0.88	0.35	0.79	1.90	6.32
Return on Equity (ROE)	-	-	-	-492.71%	-104.17%	-71.31%
Return on Assets (ROA)	-62.92%	-63.65%	-128.22%	-108.23%	-47.81%	-36.50%
Return on Capital Employed (ROCE)	-127.50%	-337.20%	235.30%	-1287.40%	-183.00%	-49.60%
Earnings Yield	-31.59%	-347.88%	-123.64%	-54.84%	-56.57%	-25.00%
FCF Yield	-	-1066.65%	-117.24%	-42.30%	-50.61%	-22.42%
Buyback Yield / Dilution	-6486.65%	-3648.83%	-63.72%	-103.32%	-146.00%	-25.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.